Mustang Bio, Inc.: Form 10-K for the period ended Dec 31, 2016
Filed with the SEC on Mar 31, 2017 and accepted by EDGAR at Mar 30, 2017, 21:54 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-10-01 to 2016-12-31 | $0 | us-gaap:SalesRevenueNet |
| Research and development | 12 months2016-01-01 to 2016-12-31 | $2.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2016-10-01 to 2016-12-31 | −$7.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months2016-01-01 to 2016-12-31 | −$11.4m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2016-10-01 to 2016-12-31 | −$8.7m | us-gaap:NetIncomeLoss |
| Net income | 12 months2016-01-01 to 2016-12-31 | −$12.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-10-01 to 2016-12-31 | −$0.64 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 12 months2016-01-01 to 2016-12-31 | −$1.15 | us-gaap:EarningsPerShareBasicAndDiluted |
| Current assets | At period end2016-12-31 | $27.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2016-12-31 | $27.5m | us-gaap:Assets |
| Current liabilities | At period end2016-12-31 | $3.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-12-31 | $3.2m | us-gaap:Liabilities |
| Shareholders' equity | At period end2016-12-31 | $24.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001144204-17-017831. Last ingested by Listed: Nov 5, 2026, 20:48 ET. Listed shows no prices and gives no investment advice.